[go: up one dir, main page]

MA39506A1 - Derivatives of 1- (cyclopent-2-en-1-yl) -3- (2-hydroxy-3- (arylsulfonyl) phenyl) urea used as cxcr2 inhibitors - Google Patents

Derivatives of 1- (cyclopent-2-en-1-yl) -3- (2-hydroxy-3- (arylsulfonyl) phenyl) urea used as cxcr2 inhibitors

Info

Publication number
MA39506A1
MA39506A1 MA39506A MA39506A MA39506A1 MA 39506 A1 MA39506 A1 MA 39506A1 MA 39506 A MA39506 A MA 39506A MA 39506 A MA39506 A MA 39506A MA 39506 A1 MA39506 A1 MA 39506A1
Authority
MA
Morocco
Prior art keywords
derivatives
cyclopent
arylsulfonyl
hydroxy
phenyl
Prior art date
Application number
MA39506A
Other languages
French (fr)
Inventor
Weichun Chen
Ebere F Igboko
Xichen Lin
Hongfu Lu
Feng Ren
Paul Bryan Wren
Zhongmiao Xu
Ting Yang
Lingdong Zhu
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Priority claimed from PCT/EP2015/061618 external-priority patent/WO2015181186A1/en
Publication of MA39506A1 publication Critical patent/MA39506A1/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des dérivés de 1-(3-sulfonylphényl)-3-(cyclopent-2-en-1-yl)-urée, et leur utilisation dans le traitement ou la prévention de maladies ou états médiés par le récepteur cxcr2. Elle concerne en outre des compositions contenant ces dérivés, et leurs méthodes de préparation.The invention relates to 1- (3-sulfonylphenyl) -3- (cyclopent-2-en-1-yl) -urea derivatives and their use in the treatment or prevention of cxcr2 receptor mediated diseases or conditions. It further relates to compositions containing these derivatives, and methods of their preparation.

MA39506A 2014-05-29 2015-05-27 Derivatives of 1- (cyclopent-2-en-1-yl) -3- (2-hydroxy-3- (arylsulfonyl) phenyl) urea used as cxcr2 inhibitors MA39506A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2014000545 2014-05-29
PCT/EP2015/061618 WO2015181186A1 (en) 2014-05-29 2015-05-27 1 -(cyclopent-2-en-1 -yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as cxcr2 inhibitors

Publications (1)

Publication Number Publication Date
MA39506A1 true MA39506A1 (en) 2018-06-29

Family

ID=58699538

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39506A MA39506A1 (en) 2014-05-29 2015-05-27 Derivatives of 1- (cyclopent-2-en-1-yl) -3- (2-hydroxy-3- (arylsulfonyl) phenyl) urea used as cxcr2 inhibitors

Country Status (2)

Country Link
AR (1) AR100636A1 (en)
MA (1) MA39506A1 (en)

Also Published As

Publication number Publication date
AR100636A1 (en) 2016-10-19

Similar Documents

Publication Publication Date Title
EA202091709A1 (en) DNA PC INHIBITORS
MA41179A (en) PARG INHIBITOR COMPOUNDS
MA40290A1 (en) Immune-regulating agents
MA47043A1 (en) Indole carboxamide compounds useful as kinase inhibitors
EA202091708A1 (en) DNA PC INHIBITORS
BR112015022462A2 (en) acid inhibitors
MA42410B1 (en) Oxysterols and their methods of use
MA53399B1 (en) Substituted pyrazoles as inhibitors of human plasma kallikrein
MA39783A (en) USEFUL QUINOXALINE DERIVATIVES AS FGFR KINASE MODULATORS
MA40955B1 (en) 2-amino-6- (difluoromethyl) -5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
MA47356A1 (en) Isochromene derivatives useful as inhibitors of phosphoinositide 3-kinases
MA46490A1 (en) Substituted 4'- fluoro-2 '- methyl nucleoside derivatives
EA201791259A1 (en) DERIVATIVES OF PIPERIDINE AS HDAC1 / 2 INHIBITORS
PH12016502347A1 (en) 1 -(cyclopent-2-en-1 -yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as cxcr2 inhibitors
MA39359A1 (en) Isoindolinone compounds as modulators of gpr119 for the treatment of diabetes, obesity and related disorders
MA46229B1 (en) Heteroaryl carboxamide compounds as inhibitors of ripk2
MA38810B1 (en) Inhibitors of rorc2 related methods of use
FR3034993B1 (en) UNIT PACKAGING, COMPOSITIONS AND THERAPEUTIC DIAGRAMS FOR THE ADMINISTRATION OF PRO-RESOLUTION PATHWAY STIMULATORS ON KERATINIC SURFACES
EA201792341A1 (en) DERIVATIVES OF PYRAZOLA SUITABLE AS INHIBITOR PROTEINS ACTIVATING 5-LIPOXYGENASE (FLAP)
MA40366A (en) TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMA INHIBITORS
MA39253B1 (en) Substituted bicyclic heteroaryl compounds used as rxr agonists
EA202190766A1 (en) IMMUNOMODULATORS, THEIR COMPOSITIONS AND METHODS OF APPLICATION
MA39506A1 (en) Derivatives of 1- (cyclopent-2-en-1-yl) -3- (2-hydroxy-3- (arylsulfonyl) phenyl) urea used as cxcr2 inhibitors
FR3038605B1 (en) VICINAL PRIMARY DIAMINS ASSOCIATED WITH CHELATING MOTIFS OF METALS AND / OR FREE RADICALS, ACTIVE AGAINST CARBONYL AND OXIDIZING STRESSES AND THEIR USE
MA44144A (en) HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS